Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating hyperthermic intraperitoneal chemotherapy (HIPEC) for metastatic pancreatic cancer with peritoneal metastasis; currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Peritoneal Carcinomatosis

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 2 | Status: RECRUITING